Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy

Abstract Immunotherapy targeting immune checkpoints has gained traction across various cancer types in clinical settings due to its notable advantages. Despite this, the overall response rates among patients remain modest, alongside issues of drug resistance and adverse effects. Hence, there is a pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiongjie Hu, Yueli Shi, Huang Wang, Liuwen Bing, Zhiyong Xu
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Experimental Hematology & Oncology
Subjects:
Online Access:https://doi.org/10.1186/s40164-025-00627-6
Tags: Add Tag
No Tags, Be the first to tag this record!